Proqr Therapeutics N v (PRQR) Annual Balance Sheets

Annual · GAAP · USD millions
Access PRQR quarterly Balance Sheets →
The data below summarizes Proqr Therapeutics N v's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents103.50
Cash & Short-term Investments103.00
Trade & Other Current Receivables (IFRS combined total)7.98
Other Current Assets8.64
Total Current Assets112.14
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent14.15
Noncurrent Assets14.15
Receivables From Taxes Other Than Income Tax-
Prepayments And Other Receivables-
Investments In Associates-
Total Assets126.29
Liabilities
Accounts Payable0.00
Longterm Borrowings0.00
Other Liabilities, Current36.33
Total Current Liabilities36.33
Total Long-term Debt0.00
Other liabilities, Noncurrent34.65
NoncurrentLeaseLiabilities10.69
Noncurrent Liabilities34.65
Current Payables On Social Security And Taxes Other Than Income Tax-
Deferred Income Classified As Current-
Other Current Liabilities8.89
Total Liabilities70.99
Stockholders' Equity
Other Equity55.30
Common Stockholder's Equity55.30
Total Stockholder's Equity55.30
Liabilities & Stockholder's Equity132.33
4 historic quarters locked

Sign in to unlock the full Proqr Therapeutics N v balance sheet history.

About Proqr Therapeutics N v Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-026713

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License